Executive Team

Dr. Martin Gleave

Executive Director, Vancouver Prostate Centre
Chief Executive Officer, PC-TRiADD
Distinguished Professor and Head, Department of Urologic Sciences, UBC
BC Leadership Chair in Prostate Cancer Research


Dr. Gleave (CM, MD, FRCSC, FACS) is a clinician-scientist and urologic surgeon. His major research focus involves the study of cellular and molecular mechanisms mediating progression of prostate cancer to its lethal stage of androgen independence, and use of this information to develop integrated multimodality therapies that specifically target these mechanisms.

Dr. Larry Goldenberg

Director of Development and Supportive Care, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, UBC
Stephen A. Jarislowski Chair in Urologic Sciences at VGH


Dr. Goldenberg (CM, OBC, MD, FRCSC, FACS, FCAHS) is a urologic surgeon and clinical scientist with an international reputation for excellence in prostate cancer research and treatment. His current research involves the evaluation of the role of multiparametric MRI in prostate cancer, the potential use of focal therapy, patient education, daVinci robotic prostatectomy and novel treatments for benign prostatic hyperplasia. He has been recognized for his contributions to health care by being inducted into the Order of British Columbia and the Order of Canada.

Dr. Paul Rennie

Director, Laboratory Research, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, UBC


Dr. Rennie is a PhD research scientist. His current research is aimed at determining how androgens regulate gene transcription and how to use this knowledge to prevent progression to androgen independence in prostate cancers. He is also studying prostate-specific elements of gene promoters and working to develop lenti and herpes virus-based vectors as a targeting vehicle for delivery and prostate-specific expression of genes that can control or kill prostate tumour cells.

Dr. Graeme Boniface

Chief Operating Officer, Vancouver Prostate Centre
Chief Operating Officer, PC-TRiADD

Dr. Boniface joined the Prostate Centre in 2008 as COO, after more than 20 years in drug development in both the academic and private industry sectors. Prior to joining our Centre, he was Senior Director of Clinical Research at QLT Inc. where he oversaw the clinical development of the company’s drug platform in Oncology, Urology, Dermatology, and Endocrinology indications. Trials conducted by his team have lead to successful regulatory marketing approvals by the US FDA, Canadian, and European agencies.

Brian Shankaruk

Chief Financial Officer, Vancouver Prostate Centre
Chief Financial Officer, PC-TRiADD

Brian Shankaruk has over 25 years experience in the financial field.  For 20 years prior to joining the Centre, Brian worked in the insurance and financial services industry, focusing on Canadian and US statutory government reporting.  Brian studied accounting at UBC and received his Certified General Accountant designation in 1990.  Much of Brian’s recent work has involved systems design and implementation, especially as it relates to operations management and government regulations.

Dr. Kim Chi

Associate Director, Clinical Research, Vancouver Prostate Centre
Senior Research Scientist, Vancouver Prostate Centre
Regional Medical Director, BC Cancer Agency – Vancouver Centre
Medical Oncologist, BC Cancer Agency – Vancouver Centre
Director, Clinical Research, BC Cancer Agency
Professor, Department of Medicine, UBC


Dr. Chi is a medical oncologist with the BC Cancer Agency who, at a relatively early stage in his career, has received national and international recognition for his contributions to prostate cancer research.

Dr. Colin Collins

Senior Research Scientist, Vancouver Prostate Centre
Director, Laboratory for Advanced Genome Analysis, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, University of British Columbia


Dr Collins is a Senior Research Scientist at the Vancouver Prostate Centre and a Director of The Laboratory for Advanced Genome Analysis (LAGA). In addition, he is an associate adjunct professor at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center and a visiting scientist at Lawrence Berkeley National Laboratory. He has held positions at Lawrence Livermore National Laboratory and Lawrence Berkeley National Laboratory at UCSF.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


2016 Step Up team

Step Up Challenge fundraiser: February 25, 2018

The annual Step Up Challenge, raising funds for Prostate Cancer Canada, takes place in Vancouver on Sunday February 25. Click here to sponsor our relay team as they climbs 379 floors. Click here to volunteer to help with the event.

It's a Snow Day poster

It's A Snow Day at Mt. Seymour: March 9

Mt. Seymour is hosting It's A Snow Day, a fundraiser for Prostate Cancer Foundation BC, on Friday March 9. The event will include slope time, a reception, and a silent auction. Click here for more details including how to register, donate and/or sponsor.




Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.